# Adjuvant Treatment of Digestive Tract Tumors

> **NCT05742620** · NA · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Adjuvant Treatment

## Interventions

- **DRUG:** anlotinib+CAPEOX/SOX

## Key facts

- **NCT ID:** NCT05742620
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06-20
- **Primary completion:** 2026-07-20
- **Final completion:** 2029-07-20
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05742620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05742620, "Adjuvant Treatment of Digestive Tract Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05742620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*